Deciphering the role of miR-22 in metabolic reprogramming and tumor suppression of hepatocellular carcinoma

被引：0

作者：

Valenti, F. ^{[1
]}

Leoni, I. ^{[2
,3
]}

Galvani, G. ^{[2
,3
]}

Monti, E. ^{[2
,3
]}

Pincigher, L. ^{[1
]}

Rizzardi, N. ^{[1
]}

Vianello, C. ^{[2
,3
]}

Negrini, M. ^{[4
]}

Domenicali, M. ^{[5
]}

Vasuri, F. ^{[6
]}

Stefanelli, C. ^{[3
]}

Gramantieri, L. ^{[7
]}

Marinelli, S. ^{[7
]}

Piscaglia, F. ^{[7
]}

Giovannini, C. ^{[2
]}

Baldassarre, M. ^{[6
]}

Ravaioli, M. ^{[8
]}

Cescon, M. ^{[8
]}

Fornari, F. ^{[2
,3
]}

Bergamini, C. ^{[1
]}

Fato, R. ^{[1
]}

机构：

[1] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy

[2] Univ Bologna, Ctr Appl Biomed Res CRBA, Policlin St Orsola, I-40138 Bologna, Italy

[3] Univ Bologna, Dept Life Qual Studies, I-47921 Rimini, Italy

[4] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy

[5] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy

[6] IRCCS Azienda Osped Univ Bologna, Dept Pathol, I-40138 Bologna, Italy

[7] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, I-40138 Bologna, Italy

[8] IRCCS Azienda Osped Univ Bologna, Dept Gen Surg & Transplantat, I-40138 Bologna, Italy

来源：

FEBS OPEN BIO | 2024年 / 14卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P-26-057

引用

页码：274 / 274

页数：1

共 50 条

[1] MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver
Gjorgjieva, Monika
Ay, Anne-Sophie
de Sousa, Marta Correia
Delangre, Etienne
Dolicka, Dobrochna
Sobolewski, Cyril
Maeder, Christine
Fournier, Margot
Sempoux, Christine
Foti, Michelangelo
CELLS, 2022, 11 (18)
[2] miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males
Jiang, Runqiu
Deng, Lei
Zhao, Liang
Li, Xiangcheng
Zhang, Feng
Xia, Yongxiang
Gao, Yun
Wang, Xuehao
Sun, Beicheng
CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5593 - 5603
[3] The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma
Hu, Nan
Li, Haiyang
Tao, Changcheng
Xiao, Ting
Rong, Weiqi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[4] The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147
Luo, Ling-Juan
Zhang, Li-Ping
Duan, Chun-Yan
Wang, Bei
He, Na-Na
Abulimiti, Patima
Lin, Yan
CANCER CELL INTERNATIONAL, 2017, 17
[5] The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147
Ling-Juan Luo
Li-Ping Zhang
Chun-Yan Duan
Bei Wang
Na-Na He
Patima Abulimiti
Yan Lin
Cancer Cell International, 17
[6] Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma
Fang, Yujia
Yan, Dong
Wang, Lixin
Zhang, Jie
He, Qingfang
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (07)
[7] MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma
Galvani, G.
Leoni, I.
Monti, E.
Vianello, C.
Marinelli, S.
Marisi, G.
Gardini, A. Casadei
Foschi, G. F.
Giovannini, C.
Baldassarre, M.
Ravaioli, M.
Cescon, M.
Vasuri, F.
Domenicali, M.
Negrini, M.
Piscaglia, F.
Stefanelli, C.
Gramantieri, L.
Fornari, F.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S96 - S97
[8] Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
Xia, Yujia
Brown, Zachary J.
Huang, Hai
Tsung, Allan
CANCER MEDICINE, 2021, 10 (18): : 6374 - 6383
[9] Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, Hayato
Hayata, Yuki
Kawamura, Satoshi
Yamada, Tomoharu
Fujiwara, Naoto
Koike, Kazuhiko
CANCERS, 2018, 10 (11):
[10] Glutamine metabolic reprogramming in hepatocellular carcinoma
Ye, Yanyan
Yu, Bodong
Wang, Hua
Yi, Fengming
FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10

← 1 2 3 4 5 →